Speaker:

A/Prof Tracy Comans and Dr Kim-Huong Nguyen

Abstract:

Health technology assessment (HTA) involves undertaking an evaluation of effectiveness and cost-effectiveness of healthcare technologies to inform funding decisions. New technologies such as pharmaceuticals, surgical and medical procedures and devices, diagnostic or screening tests, and models of care can be evaluated. Cost-effectiveness analysis is an economic evaluation approach that generates evidence-based information on the economic value (of the health technologies) to assist in and improve decision making when allocating health care resources. Australia has a long history of health technology assessment of pharmaceuticals. The Pharmaceutical Benefit Advisory Committee (PBAC) was one of the earliest international HTA bodies. Recently, the Medical Benefits Advisory Committee adopted a similar HTA process to assess non-pharmaceuticals technologies.

Speaker bios:

A/Prof ComansA/Prof Comans is an NHMRC Boosting Dementia Research Leadership Fellow in the Centre for Health Services Research, University of Queensland, and an adjunct research fellow in Metro North Hospital and Health Service. Her research involves applying economic models to investigate the cost-effectiveness of health care interventions, and leading and developing health services research focused on older people, allied health and rehabilitation services. She is the lead of the health economics sub-unit of the NHMRC Cognitive and Related Functional Decline Partnership Centre. She has degrees in physiotherapy and economics (Hons), along with a clinical background as a physiotherapist with special interests in aged care, dementia and rehabilitation.

Dr NguyenDr. Nguyen is a research fellow in Health Economics at the Centre for Health Services Research, Faculty of Medicine at the University of Queensland. Her research activities cover: economic evaluation of health technologies and social interventions; measurement and valuation of health outcomes and health preferences; measurement of productivity, efficiency and equity in healthcare; and the economics of dementia. She has more than ten years of lecturing experience in a variety of economics and health economics subjects (at UQ, QUT and Griffith University). In the past four years, she has worked as a health economist supporting research and evaluation of interventions for dementia dyads under the NHMRC’s Cognitive Decline Partnership Centre. She is currently also holding a joint appointment with Metro North Hospital and Health Service District to provide research expertise and build capacity in health economics.

About Seminar Series

The School of Pharmacy Seminar Series involves regular formal presentations of high-quality scholarly work with broad appeal.

The wider School community is invited to attend, including academic and professional staff, special guests, visitors, as well as HDR, postgraduate, masters and honours students.

Seminars are held on Fridays from 12pm–1pm in room 5034 in the Pharmacy Australia Centre of Excellence, 20 Cornwall St Woolloongabba (next to TRI and the PA Hospital).

Confirmed 2021 seminars

Date Presenter
12-1pm, Friday 19 March
(PACE R5034 and Zoom)
Professor Paul Clarke, Director Diamantina Institute        
12-1pm, Friday 16 April
(Zoom only)
Associate Professor Francine Marques, Monash University     
12-1pm, Friday 23 April
(Zoom only)
Associate Professor Ben Colagiuri, Sydney University 
12-1pm, Friday 7 May
(Zoom only)
Dr Laurence Cheung, Curtin University
12-1pm, Friday 30 July
(location TBC)
Dr Gary Chan, UQ CYSUR
12-1pm, Friday 13 August
(Zoom only)
Professor Sanjay Garg, University of South Australia
12-1pm, Friday 3 September
(PACE R5034 and Zoom)
Associate Professor Michael Barras, UQ Pharmacy
12-1pm 10 September
(Online via Zoom)

Professor Josephine Forbes, Mater Research

 

12-1pm, Friday 17 September
(PACE R5034 and Zoom)

Professor Nigel McMillan, Program Director: Infectious Diseases and Immunology, Menzies Health Institute QLD, Griffith University

12-1pm, Friday 24 September
(Location TBC)
Denuja Karunakaran, IMB Fellow, Institute for Molecular Bioscience (IMB), UQ

Venue

Pharmacy Australia Centre of Excellence, 20 Cornwall St, Woolloongabba
Room: 
5034